Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phenotype and risk factors of venom-induced anaphylaxis: A case-control study of the European Anaphylaxis Registry.
Francuzik W, Ruëff F, Bauer A, Bilò MB, Cardona V, Christoff G, Dölle-Bierke S, Ensina L, Fernández Rivas M, Hawranek T, O'B Hourihane J, Jakob T, Papadopoulos NG, Pföhler C, Poziomkowska-Gęsicka I, Van der Brempt X, Scherer Hofmeier K, Treudler R, Wagner N, Wedi B, Worm M. Francuzik W, et al. Among authors: jakob t. J Allergy Clin Immunol. 2021 Feb;147(2):653-662.e9. doi: 10.1016/j.jaci.2020.06.008. Epub 2020 Jun 22. J Allergy Clin Immunol. 2021. PMID: 32585173
Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase.
Maurer M, Altrichter S, Bieber T, Biedermann T, Bräutigam M, Seyfried S, Brehler R, Grabbe J, Hunzelmann N, Jakob T, Jung A, Kleine-Tebbe J, Mempel M, Meurer M, Reich K, Ruëff F, Schäkel K, Sengupta K, Sieder C, Simon JC, Wedi B, Zuberbier T, Mahler V, Staubach P. Maurer M, et al. Among authors: jakob t. J Allergy Clin Immunol. 2011 Jul;128(1):202-209.e5. doi: 10.1016/j.jaci.2011.04.038. Epub 2011 Jun 2. J Allergy Clin Immunol. 2011. PMID: 21636116 Clinical Trial.
Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
Dhami S, Nurmatov U, Varga EM, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Elberink JN, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Sheikh A. Dhami S, et al. Among authors: jakob t. Clin Transl Allergy. 2016 Feb 16;6:6. doi: 10.1186/s13601-016-0095-x. eCollection 2015. Clin Transl Allergy. 2016. PMID: 26885362 Free PMC article.
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Frick M, Fischer J, Helbling A, Ruëff F, Wieczorek D, Ollert M, Pfützner W, Müller S, Huss-Marp J, Dorn B, Biedermann T, Lidholm J, Ruecker G, Bantleon F, Miehe M, Spillner E, Jakob T. Frick M, et al. Among authors: jakob t. J Allergy Clin Immunol. 2016 Dec;138(6):1663-1671.e9. doi: 10.1016/j.jaci.2016.04.024. Epub 2016 May 24. J Allergy Clin Immunol. 2016. PMID: 27372568 Free article.
Component resolved diagnostics for hymenoptera venom allergy.
Jakob T, Müller U, Helbling A, Spillner E. Jakob T, et al. Curr Opin Allergy Clin Immunol. 2017 Oct;17(5):363-372. doi: 10.1097/ACI.0000000000000390. Curr Opin Allergy Clin Immunol. 2017. PMID: 28759475 Free PMC article. Review.
Erratum to: Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
Dhami S, Nurmatov U, Varga EM, Sturm G, Muraro A, Akdis CA, Antolín-Amérigo D, Bilò MB, Bokanovic D, Calderon MA, Cichocka-Jarosz E, Elberink JNGO, Gawlik R, Jakob T, Kosnik M, Lange J, Mingomataj E, Mitsias DI, Mosbech H, Pfaar O, Pitsios C, Pravettoni V, Roberts G, Ruëff F, Sin BA, Sheikh A. Dhami S, et al. Among authors: jakob t. Clin Transl Allergy. 2017 Sep 15;7:30. doi: 10.1186/s13601-017-0165-8. eCollection 2017. Clin Transl Allergy. 2017. PMID: 28932384 Free PMC article.
360 results